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The effect of glucagon and insulin on rat liver phosphorylase phosphatase activity in vivo was investigated. 
The activity of phosphatase was found to decrease following the administration of glucagon and increase 
with insulin in a reversible manner. No change was detected in the activity of heat-stable phosphatase inhibi- 
tors in the hormone-treated samples. Liver protein kinases (regulatory subunit of CAMP-dependent protein 
kinase and/or Ca*+-dependent phosphorylase kinase) are suggested to regulate the activity of hepatic phos- 
phorylase phosphatase (type 1 and 2A). 
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1. INTRODUCTION 
Reversible protein phosphorylation involving 
the action of protein kinases and phosphatases is 
the major mechanism by which hormonal control 
of glycogen metabolism is mediated [11. Activation 
of protein kinase, phosphorylase kinase and 
phosphorylase, reflecting an increase in CAMP 
concentration in the liver, was reported by 
glucagon [2]. The concentration of phosphorylase 
a may be increased due to the concerted inhibition 
of phosphorylase phosphatase (type 1 and 2A) 
with the activation of phosphorylase kinase. At 
present no such evidence is available [3]. 
insulin is capable of decreasing the level of 
cAMP in vivo provided it has previously been 
raised by a CAMP-elevating hormone, enabling it 
to antagonize the action of glucagon in the liver 
[4,5], Admi~stration of insulin to rabbits results 
in the inactivation of phosphorylase kinase and 
phosphorylase in the liver without any change in 
the concentration of CAMP [6]. 
Inhibitor-l is a powerful inhibitor of protein 
phosphatase-I only after being phosphorylated by 
* To whom correspondence should be addressed 
CAMP-dependent protein kinase. Phosphoryla- 
tion/dephosphorylation of inhibitor-l was 
demonstrated in skeletal muscle (references, see 
[7]) and in rat liver [S]. 
Here we investigated the effect of glucagon and 
insulin on rat liver phosphorylase phosphatase ac- 
tivity in viva, 
2. MATERIALS AND METHODS 
2.1. Chemicals, buffers and enzymes 
Clucagon and insulin (from bovine pancreas) 
were obtained from Sigma, Sephadex G-25 was 
supplied by Pharmacia. Other chemicals used were 
of analytical grade. 
Buffer A contained 250 mM sucrose, 50 mM 
imidazole (pH 7.4), 4 mM EDTA, 10 mM fl- 
mercaptoethanol and protease inhibitors as in 191. 
Buffer B contained 50 mM ~-glycerophosphate 
(pH 6.3), 4 mM EDTA, 10 mM ,&mercapto- 
ethanol and 100 mM NaF. 
Liver phosphorylase a and rabbit muscle “P- 
labelled phosphorylase a were prepared as in [lo] 
and [ 1 I], respectively. The catalytic subunit of pro- 
tein phosphatase-1 was prepared from rabbit 
skeletal muscle 1121 as modified in 1131. 
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2.2. Handling of animals and livers Table 1 
Experiments were performed by liver biopsy on 
fed female Wistar rats anaesthetized as in [2]. The 
abdomen was opened and the liver exposed. The 
first biopsy was taken 20 min after the beginning 
of anaesthesia. Bleeding was controlled by 
hemostatic plugs. At 5 min after the first biopsy 
was taken 0.9% NaCl or glucagon (10 ag/kg) or 
insulin (10 U/kg) plus glucose (1 g/kg) were in- 
jected intravenously and additional samples were 
cut off from different lobes. 
Phosphorylase phosphatase activity in rat liver following 
the administration of 0.9% NaCl 
Time of 
biopsy 
(min) 
Phosphatase activity (U/mg protein) 
Liver extract Sephadex G-25 filtrate 
[25 mg/ml] 
[25 mg/ml] 12.5 mg/ml] 
For the assay of phosphorylase kinase and 
phosphatase, biopsies were immediately homog- 
enized in a Potter-Elvehjem tube in 2 vols ice- 
cold buffer A. All subsequent steps were carried 
out at 0-4°C. The homogenate was centrifuged 
for 10 min at 8000 x g and 1 ml of supernatant 
was filtered through a column of Sephadex G-25 
(20 x 1.5 cm) equilibrated in buffer A. 
0 20 f 5 21 f 5 65 f 13 
7 22 f 7 23 f 6 68 + 11 
15 18 + 6 20 + 5 73 f 12 
45 23 + 5 23 + 5 69 f 13 
Liver extracts were diluted with buffer A to attain 
similar protein concentrations, and values in brackets 
indicate the protein concentration of the assay mixture. 
Activities are expressed as means + SE of 5 experiments 
For the assay of phosphorylase a the samples 
were homogenized in 10 vols ice-cold buffer B, 
centrifuged and the supernatants were used. 
2.3. Assays 
liver extract contained 30% type 1 and 70% type 
2A phosphatase [ 171. The distribution of 
phosphatase-1 and -2A, catalysing the dephos- 
phorylation of phosphorylase a, was the same in 
rat liver extract (not documented). 
Phosphorylase a was assayed as in [ 141. 
Phosphorylase phosphatase was determined with 
5 U/ml rabbit liver phosphorylase a in the 
presence of 1 mM caffeine at 37°C. One unit of 
activity of phosphatase inactivates 1 nmol phos- 
phorylase a per min under the assay condition [ 121. 
Heat-stable inhibitors were assayed in the super- 
natants of boiled liver extracts with 32P-labelled 
phosphorylase a by their ability to inhibit muscle 
phosphatase-1. One unit of inhibitor is that 
amount which inhibits 0.02 mU of phosphatase-1 
by 50% [15]. 
Phosphorylase kinase was measured as in [ 161 
using 1 mM ATP and 2 mM Mg acetate. 
As the method seemed to be suitable for detec- 
ting phosphatase activity, the effects of glucagon 
and insulin in vivo were probed. To avoid 
hypoglycemia initiating an intense glycogenolysis 
in the liver, insulin was administered together with 
glucose [18]. The activity of phosphorylase kinase 
and endogenous phosphorylase a was detected 
parallel with the phosphatase assay. In agreement 
with previous works [2,6,16] the administration of 
glucagon caused a rapid increase in the activity of 
phosphorylase kinase and insulin inactivated it 
transiently (fig. 1A). Phosphorylase a activity was 
increased by glucagon and decreased by insulin ad- 
ministered with glucose, respectively (fig. 1B). 
3. RESULTS 
In control experiments with rats treated with 
0.9% NaCl no significant changes were detected in 
liver phosphorylase phosphatase activity (table 1). 
The increase in phosphatase activity after gel filtra- 
tion and dilution is - at least in part - due to the 
decrease in the concentration of phosphatase in- 
hibitors. In the experiments below gel-filtered liver 
extracts of 25 mg/ml protein concentration were 
used. We have previously demonstrated that rabbit 
According to our results phosphorylase 
phosphatase activity is also controlled by these 
hormones. Phosphatase activity was found to 
decrease by 20-40% following the administration 
of glucagon and to return to the original value 
after 30-45 min. On the other hand, phosphatase 
was activated by 30-50% with insulin in a reversi- 
ble manner (fig.lC). Maximal effects were ob- 
tained 7 min after the addition of the hormone. 
No change was detected in the activity of heat- 
stable phosphatase inhibitors in the hormone- 
treated samples (table 2). 
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1 HORMONE A 4. DISCUSSION 
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Fig. 1. Effect of glucagon (A) and insulin plus glucose 
(0) on the activity of phosphorylase kinase (A), 
phosphorylase a (B) and phosphorylase phosphatase 
(C). Activities are expressed in units/g of protein. Values 
shown are means f SE for 4-6 experiments. 
Table 2 
Effect of glucagon and insulin plus glucose on the 
activity of heat-stable inhibitors 
Time of 
biopsy 
(min) 
Activity of heat-stable inhibitors 
(U/mg protein) in response to 
Glucagon Insulin + glucose 
0 179 f 22 179 + 22 
2 178 f 23 184 i 28 
7 180 f 27 189 + 24 
15 173 + 25 179 + 26 
30 187 f 27 171 f 28 
45 173 f 24 187 f 30 
Values are means f SE for 4 and 5 experiments, 
respectively 
Glucagon caused a transient inactivation of 
phosphatase parallel with the activation of 
phosphorylase kinase and phosphorylase. On the 
other hand, phosphatase activity was increased in 
response to insulin administered with glucose in 
concert and the inactivation of phosphorylase 
kinase, resulting in a transient inactivation of 
phosphorylase. Although glucose alone can also 
inactivate phosphorylase [181, it is not supposed to 
mask the effect of insulin, since gel filtration 
removed the low molecular mass metabolites. 
It was previously demonstrated that insulin in- 
creased phosphorylase phosphatase activity of 
hepatocytes and anaesthetized rats. Liver lobes 
were freeze-clamped and tissue extracts were 
pulverized in liquid nitrogen in these experiments 
[ 191. The hypotonic media and frozen liver can 
disrupt the native structure of phosphatase with a 
concomitant increase in the specific activity of the 
enzyme by several-fold. The latter possibility was 
clearly shown by Doper6 and Stalmans [9]. Our ex- 
perimental approach favours the preservation of 
the cellular conditions thereby the change in 
phosphorylase phosphatase activity upon hor- 
monal treatment may reflect a physiologically rele- 
vant control mechanism. 
The changes of phosphatase-1 activity in 
response to glucagon and insulin could not be 
attributed to the phosphorylation-dephospho- 
rylation of inhibitor-l as no change was detected in 
the activity of heat-stable inhibitors. On the other 
hand, the degree of phosphorylation of in- 
hibitor-l, as judged by the degree of immuno- 
fluorescence, was changed by glucagon or insulin 
in rat liver [8]. Therefore the regulatory role of 
inhibitor-l cannot be ruled out. 
Another regulatory device for type 1 and 2A 
phosphatases is offered by protein kinases. The 
regulatory subunits of type I and II CAMP- 
dependent protein kinase inhibit the dephos- 
phorylation of phosphorylase Q catalysed by 
various phosphatases [20-231. Glucagon raises the 
CAMP-concentration modulating the amount and 
the degree of phosphorylation of the regulatory 
subunit, and insulin is also capable of decreasing 
the level of CAMP. It seems that the regulatory 
subunit may control the activity of liver 
phosphorylase phosphatase-1 and -2A. Phos- 
25s 
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phorylase kinase isolated from skeletal muscle also 
inhibits protein phosphatase-1 and -2A, and the in- 
hibitory effect is several-fold larger when kinase is 
phosphorylated [24,25]. The reversible activation 
of Ca2+-dependent phosphorylase kinase occurs 
upon hormonal treatment in the liver. This process 
may also regulate the activity of hepatic 
phosphorylase phosphatase. 
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